CBS 2019
CBSMD教育中心
中 文

急性冠脉综合征

Abstract

Recommended Article

Prognostic value of fibrinogen in patients with coronary artery disease and prediabetes or diabetes following percutaneous coronary intervention: 5-year findings from a large cohort study The Potential Use of the Index of Microcirculatory Resistance to Guide Stratification of Patients for Adjunctive Therapy in Acute Myocardial Infarction Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes Long-term outcomes after myocardial infarction in middle-aged and older patients with congenital heart disease-a nationwide study Galectin-3 Levels and Outcomes After Myocardial Infarction: A Population-Based Study Effect of a Restrictive vs Liberal Blood Transfusion Strategy on Major Cardiovascular Events Among Patients With Acute Myocardial Infarction and Anemia: The REALITY Randomized Clinical Trial Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data Clinical Efficacy and Safety of Alirocumab after Acute Coronary Syndrome According to Achieved Level of Low-Density Lipoprotein Cholesterol: A Propensity Score-Matched Analysis of the ODYSSEY OUTCOMES Trial

Guideline31 August 2019

JOURNAL:Eur Heart J. Article Link

2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes: The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC)

J Knuuti, W Wijns, ESC Scientific Document Group et al. Keywords: guidelines, chronic coronary syndromes, angina pectoris, myocardial ischaemia, coronary artery disease, diagnostic testing, imaging, risk assessment, lifestyle modifications, anti-ischaemic drugs, antithrombotic therapy, lipid-lowering drugs, myocardial revascularization, microvascular angina, vasospastic angina, screening

FULL TEXT PDF